Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Casi Phrmactcls Inc (NQ: CASI )

2.180 USD -0.210 (-8.79%)
Official Closing Price Updated: 7:03 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Casi Phrmactcls Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business Updates
~ Expects to Report EVOMELA® (melphalan for injection) Fourth Quarter 2020 Unaudited Revenue of Approximately $4.8 Million and Full-Year 2020 Unaudited Revenue of Approximately $15 Million, exceeding... 
From PR Newswire
CASI Pharmaceuticals Partner, BioInvent, Presents Phase I/IIA Data That Suggests BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients
-Responses in 6 out of 9 patients evaluated provide exciting evidence that BI-1206 has the potential to restore activity of rituximab in non-Hodgkin's lymphoma patients who have relapsed after... 
From PR Newswire
BioInvent Phase I/IIa data suggest BI-1206 restores activity of rituximab in relapsed non-Hodgkin's lymphoma patients
Responses in 6 out of 9 patients evaluated provide exciting evidence that BI-1206 has the potential to restore activity of rituximab in non-Hodgkin's lymphoma patients who have relapsed after treatment... 
From PR Newswire
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Top Stories DMTK Earnings
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
This morning 163 companies set new 52-week highs. Areas of Significance: The largest company by market cap ... 
Tags 52/Week Highs MSN GLO
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Edesa Biotech (NASDAQ:EDSA) stock moved upwards by 99.63% to $11.04 during Tuesday's pre-market session. The ... 
Tags UBX AIKI NVIV
From Benzinga
Top Penny Stocks On Robinhood To Watch If Biotech Is Your Focus Now
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
CASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion Leader Call On BI-1206 For Relapsed Or Refractory Non-Hodgkin's Lymphoma
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that its... 
From PR Newswire
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Benzinga CORT ALKS
From Benzinga
BioInvent to host Key Opinion Leader call on BI-1206 for relapsed or refractory Non-Hodgkin's Lymphoma
BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy today... 
From PR Newswire
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TXG SYNH RCUS
From Benzinga
CASI Pharmaceuticals, Inc. To Present At H.C. Wainwright Bioconnect Conference
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces that Dr.... 
From PR Newswire
Week In Review: Beijing's Jacobio Completes $174 Million Hong Kong IPO
Jacobio of Beijing raised $174 million in a Hong Kong IPO to develop its portfolio of 12 novel drugs. Transcenta Holding completed a $105 million funding round to support its global antibody drug... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Week in Review: Beijing's Jacobio Completes $174 Million Hong Kong IPO
Deals and Financings Jacobio of Beijing raised $174 million in a Hong Kong IPO to develop its portfolio of 12 novel drugs, developed in-house to be best-in-class therapies; China 's Transcenta Holding... 
From ChinaBio® Today
Thinking about buying stock in CASI Pharmaceuticals, FuelCell Energy, Ampio Pharmaceuticals, Mohawk Group, or Perion Network?
InvestorsObserver issues critical PriceWatch Alerts for CASI, FCEL, AMPE, MWK, and PERI. 
From PR Newswire
CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough Therapy Designation
- Second CAR-T 19 drug in global development (and first CAR-T 19 drug developed locally in China) to receive China Breakthrough Therapy Designation - 
From PR Newswire
CASI Granted Breakthrough Status in China for CD19 CAR-T Therapy
CASI Pharma, a US-China biopharma, announced its partnered CD19 CAR-T product was granted Breakthrough Designation in China for relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). In 2019,... 
From ChinaBio® Today
Penny Stocks To Watch Before 2021 Up Big In Q4
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces the... 
From PR Newswire
72 Biggest Movers From Friday
Gainers AbCellera Biologics Inc. (NASDAQ: ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 ... 
Tags XERS SLDB BRN
From Benzinga
12 Healthcare Stocks Moving In Friday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) stock rose 75.94% to $2.2 during Friday's regular session. Trading volume for ... 
Tags SAGE Top Gainers SNDL
From Benzinga
Wednesday 11/25 Insider Buying Report: CASI, CHMA
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... 
Tags Stocks
From Market News Video
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares rose 94.86% to $6.82 during Wednesday's pre-market session. ... 
Tags PROG healthcare stocks HEPA
From Benzinga
CASI Pharmaceuticals Announces Partner Juventas Completes $65 Million Financing And Initiates Registration Study For CNCT19 (CD19 CAR-T)
CASI to Co-Commercialize CNCT19, with Additional Rights to a Second Product from Juventas' Cell Therapy Pipeline 
From PR Newswire
CASI Pharmaceuticals: Q3 Earnings Insights
Shares of CASI Pharmaceuticals (NASDAQ:CASI) remained unaffected after the company reported Q3 results. Quarterly Results Earnings ... 
Tags CASI Earnings Benzinga
From Benzinga
CASI Pharmaceuticals Announces Third Quarter 2020 Financial Results
- EVOMELA Third Quarter 2020 Revenue Exceeds Expectations; Company Increasing EVOMELA Full-Year Revenue Guidance for 2020 - 
From PR Newswire
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ADXS CBAY PTE
From Benzinga
CASI Pharmaceuticals To Report Third Quarter 2020 Financial Results And Host Conference Call November 9, 2020
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company... 
From PR Newswire
54 Biggest Movers From Yesterday
Gainers Endurance International Group Holdings, Inc. (NASDAQ: EIGI) shares jumped 62% to close at $9.41 on Monday after the ... 
Tags CVA PRPH EIGI
From Benzinga
Week In Review: CStone Out-Licenses Ex-China Rights To Two Immunotherapies In $1.3 Billion Deal
CStone Pharma out-licensed global rights for two immunoncology assets to US-based EQRx in a $1.3 billion agreement. CStone will receive $150 million upfront and up to $1.15 billion in milestone... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.